Search by Drug Name or NDC

NDC 52937-0101-08 Vascepa 1000 mg/1 Details

Vascepa 1000 mg/1

Vascepa is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amarin Pharma Inc.. The primary component is ICOSAPENT ETHYL.

MedlinePlus Drug Summary

Icosapent ethyl is used together with lifestyle changes (diet, weight loss, exercise) to reduce the amount of triglycerides (a fat-like substance) in the blood. It is also used along with cholesterol-lowering medications (statins) to decrease the risk of a heart attack, a stroke, or other heart problems that require hospitalization in certain adults with high triglyceride levels and heart disease or diabetes with 2 or more other heart disease risk factors. Icosapent ethyl is in a class of medications called antilipemic or lipid-regulating agents. Icosapent ethyl may work by decreasing the amount of triglycerides and other fats made in the liver.

Related Packages: 52937-0101-08
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Icosapent Ethyl

Product Information

NDC	52937-0101
Product ID	52937-101_3cbbd4ee-5c31-4ed9-a39c-01b3529967f9
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Vascepa
Proprietary Name Suffix	n/a
Non-Proprietary Name	icosapent ethyl
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	1000
Active Ingredient Units	mg/1
Substance Name	ICOSAPENT ETHYL
Labeler Name	Amarin Pharma Inc.
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA202057
Listing Certified Through	2024-12-31

Package

NDC 52937-0101-08 (52937010108)

Pricing Information	N/A
NDC Package Code	52937-101-08
Billing NDC	52937010108
Package	1 BLISTER PACK in 1 CARTON (52937-101-08) / 8 CAPSULE in 1 BLISTER PACK
Marketing Start Date	2012-10-01
NDC Exclude Flag	N